Combining mirror therapy and augmented reality for stroke rehabilitation
Outcomes of Mirror Therapy Preceding Augmented Reality in Stroke Rehabilitation
This study tests whether using a combination of mirror therapy and augmented reality can help people who have had a stroke recover better and faster.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 75 (estimated) |
| Ages | 30 Years to 80 Years |
| Sex | All |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 5 sites (New Taipei City and 4 other locations) |
| Trial ID | NCT05993091 on ClinicalTrials.gov |
What this trial studies
This research aims to explore innovative treatment strategies for stroke rehabilitation by combining mirror therapy (MT) with augmented reality (AR). The study focuses on patients who have experienced a first-ever unilateral stroke and are within 3 months to 3 years post-event. By utilizing AR, the intervention provides an intensive and context-rich training program that enhances motivation and participation through real-time feedback. The goal is to create an enriched neuroplastic environment that facilitates motor and functional recovery in stroke patients.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 30 to 80 who have experienced a first-ever unilateral stroke between 3 months and 3 years prior.
Not a fit: Patients with severe spasticity, acute inflammation, or other serious medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve rehabilitation outcomes for stroke patients, enhancing their recovery and quality of life.
How similar studies have performed: While the combination of MT and AR is a novel approach, previous studies have shown promise in using these individual therapies for stroke rehabilitation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. a first-ever unilateral stroke ≥3 months and ≤3 years 2. age between 30 and 80 years (Kwakkel et al., 1999) 3. baseline Fugl-Meyer Assessment Upper Extremity (FMA-UE) score \>10 (Fugl-Meyer et al., 1975) 4. no severe spasticity in any joints of the affected arm (modified Ashworth scale \<3) (Charalambous, 2014) 5. ability to follow the instructions of the evaluator and therapists 6. the ability to maintain a step-standing position for at least 30 seconds (Lloréns et al., 2015) 7. ability to walk a minimum of 10 meters, with or without a device (Park et al., 2017) 8. no severe vision impairments or other major neurologic diseases 9. no participation in other studies during the study period 10. willingness to provide informed written consent. Exclusion Criteria: 1. acute inflammation 2. serious medical problems or poor physical conditions that might be detrimental to study participation.
Where this trial is running
New Taipei City and 4 other locations
- Taipei Hospital, Ministry of Health and Welfare — New Taipei City, Taiwan (Recruiting)
- Taipei Tzu Chi Hospital, Buddhist Tzu Chi Foundation — New Taipei City, Taiwan (Recruiting)
- Fongyuan Hospital, Ministry of Health and Welfare — Taichung, Taiwan (Recruiting)
- National Taiwan University Hospital — Taipei, Taiwan (Recruiting)
- Wan Fang Hospital, Taipei Medical University — Taipei, Taiwan (Recruiting)
Study contacts
- Principal investigator: Keh-chung Lin, ScD — National Taiwan University Hospital
- Study coordinator: Keh-chung Lin, ScD
- Email: kehchunglin@ntu.edu.tw
- Phone: +886-3366-8180
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.